Commission Implementing Regulation (EU) 2020/165 of 5 February 2020 concerning the authorisation of endo-1,4-beta-mannanase produced by Paenibacillus lentus DSM 32052 as a feed additive for chickens for fattening, for chickens reared for laying, turkeys for fattening or reared for breeding and for minor poultry species and repealing Regulation (EC) No 786/2007 (holder of authorisation Elanco GmbH) (Text with EEA relevance)

Type Implementing Regulation
Publication 2020-02-06
State In force
Text As published
Department European Commission, SANTE
Source EUR-Lex
articles 4

This is the act as published. Later amendments are not folded into the text below: each one is a separate act in this repository and an entry in this law's history.

Reform history JSON API
6.2.2020 EN Official Journal of the European Union L 34/40

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Regulation (EC) No 1831/2003 of the European Parliament and of the Council of 22 September 2003 on additives for use in animal nutrition 1, and in particular Article 9(2) thereof,

Whereas:

HAS ADOPTED THIS REGULATION:

Article 1

The authorisation of the additive specified in the Annex, belonging to the additive category ‘zootechnical additives’ and to the functional group ‘digestibility enhancers’, is renewed subject to the conditions laid down in that Annex.

Article 2

Regulation (EC) No 786/2007 is repealed.

Article 3

Endo-1,4-beta-mannanase produced by Paenibacillus lentus ATCC 55045, premixtures and compound feed containing that substance, which are produced and labelled before 26 February 2020 in accordance with the rules applicable before 26 February 2020 may continue to be placed on the market and used until the existing stock are exhausted.

Article 4

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 5 February 2020.

For the Commission

The President

Ursula VON DER LEYEN

2

Commission Regulation (EC) No 786/2007 of 4 July 2007 concerning the authorisation of endo-1,4-beta-mannanase EC 3.2.1.78 (Hemicell) as a feed additive (OJ L 175, 5.7.2007, p. 8).

3

EFSA Journal 2019;17(3):5641.

ANNEX

Identification number of the additive Name of the holder of authorisation Additive Composition, chemical formula, description, analytical method Species or category of animal Maximum age Minimum content Maximum content Other provisions End of period of authorisation
Identification number of the additive Name of the holder of authorisation Additive Composition, chemical formula, description, analytical method Species or category of animal Maximum age Unit of activity/kg of complete feedingstuff with a moisture content of 12 % Unit of activity/kg of complete feedingstuff with a moisture content of 12 % Other provisions End of period of authorisation
Category of zootechnical additives. Functional group: digestibility enhancers Category of zootechnical additives. Functional group: digestibility enhancers Category of zootechnical additives. Functional group: digestibility enhancers Category of zootechnical additives. Functional group: digestibility enhancers Category of zootechnical additives. Functional group: digestibility enhancers Category of zootechnical additives. Functional group: digestibility enhancers Category of zootechnical additives. Functional group: digestibility enhancers Category of zootechnical additives. Functional group: digestibility enhancers Category of zootechnical additives. Functional group: digestibility enhancers Category of zootechnical additives. Functional group: digestibility enhancers
4a3i Elanco GmbH Endo-1,4-beta-mannanase EC 3.2.1.78 Additive composition Preparation of endo-1,4-beta-mannanase, produced by Paenibacillus lentus (DSM 32052) having a minimum activity of 7,2 × 105 U4/ml Liquid form Characterisation of the active substance Endo-1,4-beta-mannanase produced by Paenibacillus lentus (DSM 32052) Analytical method 5 colorimetric method based on the reaction between reducing sugars (mannose equivalent) with 3,5-dinitrosalicylic acid (DNS) Chickens for fattening - 79 200 U - 1. In the directions for use of the additive and premixtures, the storage conditions and stability to heat treatment shall be indicated. 2. For users of the additive and premixtures, feed business operators shall establish operational procedures and organisational measures to address potential risks resulting from its use. Where those risks cannot be eliminated or reduced to a minimum by such procedures and measures, the additive and premixtures shall be used with personal protective equipment, including breathing protection. 26.2.2030
4a3i Elanco GmbH Endo-1,4-beta-mannanase EC 3.2.1.78 Additive composition Preparation of endo-1,4-beta-mannanase, produced by Paenibacillus lentus (DSM 32052) having a minimum activity of 7,2 × 105 U4/ml Liquid form Characterisation of the active substance Endo-1,4-beta-mannanase produced by Paenibacillus lentus (DSM 32052) Analytical method 5 colorimetric method based on the reaction between reducing sugars (mannose equivalent) with 3,5-dinitrosalicylic acid (DNS) Turkeys for fattening - 79 200 U - 1. In the directions for use of the additive and premixtures, the storage conditions and stability to heat treatment shall be indicated. 2. For users of the additive and premixtures, feed business operators shall establish operational procedures and organisational measures to address potential risks resulting from its use. Where those risks cannot be eliminated or reduced to a minimum by such procedures and measures, the additive and premixtures shall be used with personal protective equipment, including breathing protection. 26.2.2030
4a3i Elanco GmbH Endo-1,4-beta-mannanase EC 3.2.1.78 Additive composition Preparation of endo-1,4-beta-mannanase, produced by Paenibacillus lentus (DSM 32052) having a minimum activity of 7,2 × 105 U4/ml Liquid form Characterisation of the active substance Endo-1,4-beta-mannanase produced by Paenibacillus lentus (DSM 32052) Analytical method 5 colorimetric method based on the reaction between reducing sugars (mannose equivalent) with 3,5-dinitrosalicylic acid (DNS) Chickens reared for laying - 79 200 U - 1. In the directions for use of the additive and premixtures, the storage conditions and stability to heat treatment shall be indicated. 2. For users of the additive and premixtures, feed business operators shall establish operational procedures and organisational measures to address potential risks resulting from its use. Where those risks cannot be eliminated or reduced to a minimum by such procedures and measures, the additive and premixtures shall be used with personal protective equipment, including breathing protection. 26.2.2030
4a3i Elanco GmbH Endo-1,4-beta-mannanase EC 3.2.1.78 Additive composition Preparation of endo-1,4-beta-mannanase, produced by Paenibacillus lentus (DSM 32052) having a minimum activity of 7,2 × 105 U4/ml Liquid form Characterisation of the active substance Endo-1,4-beta-mannanase produced by Paenibacillus lentus (DSM 32052) Analytical method 5 colorimetric method based on the reaction between reducing sugars (mannose equivalent) with 3,5-dinitrosalicylic acid (DNS) Turkeys reared for breeding - 79 200 U - 1. In the directions for use of the additive and premixtures, the storage conditions and stability to heat treatment shall be indicated. 2. For users of the additive and premixtures, feed business operators shall establish operational procedures and organisational measures to address potential risks resulting from its use. Where those risks cannot be eliminated or reduced to a minimum by such procedures and measures, the additive and premixtures shall be used with personal protective equipment, including breathing protection. 26.2.2030
4a3i Elanco GmbH Endo-1,4-beta-mannanase EC 3.2.1.78 Additive composition Preparation of endo-1,4-beta-mannanase, produced by Paenibacillus lentus (DSM 32052) having a minimum activity of 7,2 × 105 U4/ml Liquid form Characterisation of the active substance Endo-1,4-beta-mannanase produced by Paenibacillus lentus (DSM 32052) Analytical method 5 colorimetric method based on the reaction between reducing sugars (mannose equivalent) with 3,5-dinitrosalicylic acid (DNS) Minor poultry species for fattening or reared for laying/breeding - 79 200 U - 1. In the directions for use of the additive and premixtures, the storage conditions and stability to heat treatment shall be indicated. 2. For users of the additive and premixtures, feed business operators shall establish operational procedures and organisational measures to address potential risks resulting from its use. Where those risks cannot be eliminated or reduced to a minimum by such procedures and measures, the additive and premixtures shall be used with personal protective equipment, including breathing protection. 26.2.2030
4

One unit of activity (U) is the amount of the enzyme which liberates 0,72 micrograms of reducing sugars (mannose equivalents) from a mannan-containing substrate (locust bean gum) per minute at pH 7,5 and 40 °C.

5

Details of the analytical methods are available at the following address of the Reference Laboratory: https://ec.europa.eu/jrc/en/eurl/feed-additives/evaluation-reports

Reading this document does not replace reading the official text published in the Official Journal of the European Union. We assume no responsibility for any inaccuracies arising from the conversion of the original to this format.

This text is published under EUR-Lex's own terms of reuse, not a Legalize or public-domain licence. EUR-Lex
Creative Commons Attribution 4.0 International (CC BY 4.0)
© European Union, https://eur-lex.europa.eu — Source: EUR-Lex (Publications Office of the European Union). Reused under the Creative Commons Attribution 4.0 International (CC BY 4.0) licence. Only EU legislation published in the printed Official Journal of the European Union is deemed authentic; consolidated texts are reproduced here for documentation purposes and have been reformatted to Markdown.